*:Co-first author; #:Co-corresponding author
1. Dai CY*, Tang YG*, Yang HH, Zheng JF. YTHDC1 lactylation regulates its phase separation to enhance target mRNA stability and promote RCC progression. Mol Cell. Cover paper. 2025, 85(14), 2733-2748.e7. DOI: 10.1016/j.molcel.2025.06.017
2. Tang YG*, Dai CY*,,Yang HH*, YangX*, ChenZY, DouJX, ZhangLX, BaiT#, Zheng JF#. KAT8-mediated MDH2 lactylation promotes renal cancer progression by enhancing mitochondrial function and stress resistance. Int J Biol Macromol. 2025, 322(Pt 1), 146571. DOI: 10.1016/j.ijbiomac.2025.146571
3. Ma YZ*, Fang ZY*, Zhang HN*, Qi YJ, Mao YK, Zheng JF. PDZK1 suppresses TNBC development and sensitizes TNBC cells to erlotinib via the EGFR pathway. Cell Death Dis. 2024, 15(3), 199. DOI: 10.1038/s41419-024-06502-2
4. Dai CY*, Cao JF*, Tang YG, Jiang YX, Luo CH#, Zheng JF#. YTHDF3 phase separation regulates ccRCC development via HSPA13-dependent immune evasion. Cancer Sci. 2024, 115(8), 2588-2601. DOI: 10.1111/cas.16228
5. Qi YJ*, Ma YZ*, Peng ZQ, Wang L, Li LX, Tang YL, He JQ, Zheng JF. Long noncoding RNA PENG upregulates PDZK1 expression by sponging miR-15b to suppress clear cell renal cell carcinoma cell proliferation. Oncogene. 2020, 39(22), 4404-4420. DOI: 10.1038/s41388-020-1297-1
6. Ma YZ*, Qi YJ*, Wang L, Zheng ZX, Zhang Y, Zheng JF. SIRT5-mediated SDHA desuccinylation promotes clear cell renal cell carcinoma tumorigenesis. Free Radic Biol Med. 2019, 134, 458-467. DOI: 10.1016/j.freeradbiomed.2019.01.030
Honors and Awards:
Capital Medical University Natural Science Award, Third Prize (2024, 2023, 2022)
Capital Medical University English Teaching Competition: First Prize, School of Basic Medical Sciences (2012); Third Prize, University-wide (2012)
Avon Foundation-AACR International Travel Grant for the American Association for Cancer Research (AACR) 102nd Annual Meeting (Awarded 2010, for 2011 Meeting)
Eurasia-Pacific Uninet Scholarship (2007)